Literature DB >> 22289794

The tubule pathology of septic acute kidney injury: a neglected area of research comes of age.

Manjeri A Venkatachalam1, Joel M Weinberg.   

Abstract

Oxidant stress and compromised microcirculation underlie renal pathophysiology in septic acute kidney injury (AKI). Holthoff et al. report that resveratrol ameliorates these coupled abnormalities. They did not establish the primacy of either defect in septic AKI. However, tubule mitochondrial defects were recently reported to be involved in septic AKI pathogenesis, and resveratrol targets PGC-1α and respiratory enzymes. Together, these findings open new avenues for research into long-unresolved issues in the pathophysiology of septic AKI.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289794      PMCID: PMC3395426          DOI: 10.1038/ki.2011.401

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

Review 1.  The pathophysiology and treatment of sepsis.

Authors:  Richard S Hotchkiss; Irene E Karl
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

Review 2.  Acute renal failure and sepsis.

Authors:  Robert W Schrier; Wei Wang
Journal:  N Engl J Med       Date:  2004-07-08       Impact factor: 91.245

3.  Effects of the inducible nitric-oxide synthase inhibitor L-N(6)-(1-iminoethyl)-lysine on microcirculation and reactive nitrogen species generation in the kidney following lipopolysaccharide administration in mice.

Authors:  Liping Wu; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2007-01-03       Impact factor: 4.030

4.  Acute renal success. The unexpected logic of oliguria in acute renal failure.

Authors:  K Thurau; J W Boylan
Journal:  Am J Med       Date:  1976-09       Impact factor: 4.965

5.  Nephron stop-flow pressure response to obstruction for 24 hours in the rat kidney.

Authors:  W J Arendshorst; W F Finn; C W Gottschalk
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

6.  Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney.

Authors:  Patrick N Cunningham; Hristem M Dyanov; Pierce Park; Jun Wang; Kenneth A Newell; Richard J Quigg
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Tumor necrosis factor-alpha mRNA expression in lipopolysaccharide-stimulated rat kidney. Chronological analysis of localization.

Authors:  E Noiri; S Kuwata; K Nosaka; K Tokunaga; T Juji; Y Shibata; K Kurokawa
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

8.  Evidence for the role of reactive nitrogen species in polymicrobial sepsis-induced renal peritubular capillary dysfunction and tubular injury.

Authors:  Liping Wu; Neriman Gokden; Philip R Mayeux
Journal:  J Am Soc Nephrol       Date:  2007-05-09       Impact factor: 10.121

9.  Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure.

Authors:  Wei Wang; Suparoek Jittikanont; Sandor A Falk; Ping Li; Lili Feng; Patricia E Gengaro; Brian D Poole; Russell P Bowler; Brian J Day; James D Crapo; Robert W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2003-03

10.  Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure.

Authors:  Masayo Naito; Karol Bomsztyk; Richard A Zager
Journal:  J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 10.121

View more
  14 in total

1.  Renal Hemodynamics in AKI: In Search of New Treatment Targets.

Authors:  Martin Matejovic; Can Ince; Lakhmir S Chawla; Roland Blantz; Bruce A Molitoris; Mitchell H Rosner; Mark D Okusa; John A Kellum; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2015-10-28       Impact factor: 10.121

2.  Rolipram improves renal perfusion and function during sepsis in the mouse.

Authors:  Joseph H Holthoff; Zhen Wang; Naeem K Patil; Neriman Gokden; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2013-09-09       Impact factor: 4.030

3.  Renal tubular cell spliced X-box binding protein 1 (Xbp1s) has a unique role in sepsis-induced acute kidney injury and inflammation.

Authors:  Silvia Ferrè; Yingfeng Deng; Sarah C Huen; Christopher Y Lu; Philipp E Scherer; Peter Igarashi; Orson W Moe
Journal:  Kidney Int       Date:  2019-08-01       Impact factor: 10.612

4.  The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice.

Authors:  Andreas Linkermann; Jan-Ole Heller; Agnes Prókai; Joel M Weinberg; Federica De Zen; Nina Himmerkus; Attila J Szabó; Jan H Bräsen; Ulrich Kunzendorf; Stefan Krautwald
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

Review 5.  Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss.

Authors:  Francesca Maremonti; Claudia Meyer; Andreas Linkermann
Journal:  J Am Soc Nephrol       Date:  2022-01-12       Impact factor: 10.121

Review 6.  Fluid management for the prevention and attenuation of acute kidney injury.

Authors:  John R Prowle; Christopher J Kirwan; Rinaldo Bellomo
Journal:  Nat Rev Nephrol       Date:  2013-11-12       Impact factor: 28.314

7.  cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury.

Authors:  Ryan M Whitaker; Lauren P Wills; L Jay Stallons; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

8.  Lumen LPS inhibits HCO3(-) absorption in the medullary thick ascending limb through TLR4-PI3K-Akt-mTOR-dependent inhibition of basolateral Na+/H+ exchange.

Authors:  Bruns A Watts; Thampi George; David W Good
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22

Review 9.  Acute kidney injury: an intensivist's perspective.

Authors:  John R Prowle
Journal:  Pediatr Nephrol       Date:  2013-01-30       Impact factor: 3.714

10.  Panaxadiol Saponin and Dexamethasone Improve Renal Function in Lipopolysaccharide-Induced Mouse Model of Acute Kidney Injury.

Authors:  Yan Chen; Yanwei Du; Yang Li; Xiaoqin Wang; Pin Gao; Guang Yang; Yuan Fang; Yan Meng; Xuejian Zhao
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.